US Patent Issued to Board of Regents, The University of Texas System on Aug. 4 for "Anti-BST2 antibodies targeting BST2 long isoform" (Texas Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,335, issued on Aug. 4, was assigned to Board of Regents, The University of Texas System (Austin, Texas).

"Anti-BST2 antibodies targeting BST2 long isoform" was invented by Laura Del Carmen Bover (Houston), Felipe Amaya-Manzanares (Houston), Long Vien (Houston), Ahmed Muhsin (Houston), Janis D Johnson (Houston), Julio Pollarolo (Houston) and Zhuang Wu (Houston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Embodiments of the disclosure include methods and compositions directed to targeting of cells that express the long form of Bone marrow stromal cell antigen 2 (BST2) protein, including cancer cells that express the long isoform of BST2. In particula...